UnitedHealth Group Incorporated $UNH Shares Sold by Ferguson Wellman Capital Management Inc.

Ferguson Wellman Capital Management Inc. reduced its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 82.5% during the 2nd quarter, HoldingsChannel reports. The firm owned 33,063 shares of the healthcare conglomerate’s stock after selling 155,436 shares during the period. Ferguson Wellman Capital Management Inc.’s holdings in UnitedHealth Group were worth $10,315,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Exchange Traded Concepts LLC boosted its holdings in UnitedHealth Group by 48.0% during the second quarter. Exchange Traded Concepts LLC now owns 4,184 shares of the healthcare conglomerate’s stock worth $1,305,000 after buying an additional 1,357 shares in the last quarter. NorthCrest Asset Manangement LLC raised its position in shares of UnitedHealth Group by 9.6% in the second quarter. NorthCrest Asset Manangement LLC now owns 23,639 shares of the healthcare conglomerate’s stock valued at $7,294,000 after buying an additional 2,068 shares during the last quarter. Community Trust & Investment Co. raised its position in shares of UnitedHealth Group by 4.2% in the second quarter. Community Trust & Investment Co. now owns 61,680 shares of the healthcare conglomerate’s stock valued at $19,242,000 after buying an additional 2,495 shares during the last quarter. Atticus Wealth Management LLC grew its holdings in UnitedHealth Group by 101.9% in the second quarter. Atticus Wealth Management LLC now owns 731 shares of the healthcare conglomerate’s stock valued at $228,000 after purchasing an additional 369 shares during the period. Finally, Mn Services Vermogensbeheer B.V. increased its position in shares of UnitedHealth Group by 0.6% in the second quarter. Mn Services Vermogensbeheer B.V. now owns 342,000 shares of the healthcare conglomerate’s stock worth $106,694,000 after acquiring an additional 2,000 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 2.0%

UnitedHealth Group stock opened at $334.74 on Friday. The firm’s 50-day moving average is $295.01 and its 200-day moving average is $366.14. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The company has a market cap of $303.16 billion, a P/E ratio of 14.50, a PEG ratio of 2.23 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same period last year, the business earned $6.80 EPS. The firm’s revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be paid a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.6%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 38.30%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on UNH shares. Baird R W downgraded shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research note on Thursday, July 31st. Piper Sandler decreased their target price on shares of UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating for the company in a research note on Wednesday, July 30th. Wall Street Zen downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Saturday, May 24th. Sanford C. Bernstein increased their price objective on shares of UnitedHealth Group from $337.00 to $379.00 and gave the company an “outperform” rating in a research note on Friday, September 5th. Finally, JPMorgan Chase & Co. reduced their price objective on shares of UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating on the stock in a research note on Wednesday, August 6th. Sixteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $358.95.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.